• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人CD4+ T细胞在一种抗体样免疫受体规避MHC II类限制后,通过颗粒酶/穿孔素裂解靶细胞。

Human CD4+ T cells lyse target cells via granzyme/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptor.

作者信息

Hombach Andreas, Köhler Heike, Rappl Gunter, Abken Hinrich

机构信息

Klinik I für Innere Medizin, Labor Tumorgenetik, and Zentrum für Molekulare Medizin Köln, Universität zu Köln, Köln, Germany.

出版信息

J Immunol. 2006 Oct 15;177(8):5668-75. doi: 10.4049/jimmunol.177.8.5668.

DOI:10.4049/jimmunol.177.8.5668
PMID:17015756
Abstract

Immune elimination of tumor cells requires the close cooperation between CD8+ CTL and CD4+ Th cells. We circumvent MHC class II-restriction of CD4+ T cells by expression of a recombinant immunoreceptor with an Ab-derived binding domain redirecting specificity. Human CD4+ T cells grafted with an immunoreceptor specific for carcinoembryonic Ag (CEA) are activated to proliferate and secrete cytokines upon binding to CEA+ target cells. Notably, redirected CD4+ T cells mediate cytolysis of CEA+ tumor cells with high efficiencies. Lysis by redirected CD4+ T cells is independent of death receptor signaling via TNF-alpha or Fas, but mediated by perforin and granzyme because cytolysis is inhibited by blocking the release of cytotoxic granules, but not by blocking of Fas ligand or TNF-alpha. CD4+ T cells redirected by Ab-derived immunoreceptors in a MHC class II-independent fashion substantially extend the power of an adoptive, Ag-triggered immunotherapy not only by CD4+ T cell help, but also by cytolytic effector functions. Because cytolysis is predominantly mediated via granzyme/perforin, target cells that are resistant to death receptor signaling become sensitive to a cytolytic attack by engineered CD4+ T cells.

摘要

肿瘤细胞的免疫清除需要CD8⁺细胞毒性T淋巴细胞(CTL)和CD4⁺辅助性T细胞(Th细胞)密切合作。我们通过表达一种带有源自抗体的结合结构域以重定向特异性的重组免疫受体,规避了CD4⁺T细胞的MHC II类限制。移植了对癌胚抗原(CEA)具有特异性的免疫受体的人CD4⁺T细胞,在与CEA⁺靶细胞结合后被激活,从而增殖并分泌细胞因子。值得注意的是,重定向的CD4⁺T细胞能高效介导CEA⁺肿瘤细胞的细胞溶解。重定向的CD4⁺T细胞介导的细胞溶解不依赖于通过肿瘤坏死因子-α(TNF-α)或Fas的死亡受体信号传导,而是由穿孔素和颗粒酶介导,因为细胞溶解可通过阻断细胞毒性颗粒的释放而受到抑制,但不能通过阻断Fas配体或TNF-α来抑制。以不依赖MHC II类的方式由源自抗体的免疫受体重定向的CD4⁺T细胞,不仅通过CD4⁺T细胞的辅助作用,还通过细胞溶解效应功能,极大地扩展了过继性、抗原触发的免疫疗法的效能。由于细胞溶解主要通过颗粒酶/穿孔素介导,对死亡受体信号传导有抗性的靶细胞对工程化CD4⁺T细胞的细胞溶解攻击变得敏感。

相似文献

1
Human CD4+ T cells lyse target cells via granzyme/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptor.人CD4+ T细胞在一种抗体样免疫受体规避MHC II类限制后,通过颗粒酶/穿孔素裂解靶细胞。
J Immunol. 2006 Oct 15;177(8):5668-75. doi: 10.4049/jimmunol.177.8.5668.
2
CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion.移植了重组免疫受体的CD4+ T细胞能够以不依赖MHC抗原和Fas的方式有效裂解靶细胞。
J Immunol. 2001 Jul 15;167(2):1090-6. doi: 10.4049/jimmunol.167.2.1090.
3
Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.活化的人外周血T细胞亚群所表现出的多种细胞溶解机制。
J Immunol. 1992 Jan 1;148(1):55-62.
4
Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.抗独特型抗体在人癌胚抗原转基因小鼠中诱导细胞免疫。
Immunology. 2006 Aug;118(4):483-96. doi: 10.1111/j.1365-2567.2006.02391.x.
5
Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.人纯化蛋白衍生物特异性CD4 + T细胞使用CD95依赖性和CD95非依赖性细胞溶解机制。
J Immunol. 1998 Mar 1;160(5):2374-9.
6
CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.CD4(+)和CD8(+) T细胞通过一种不依赖穿孔素和Fas/Fas配体的机制杀死细胞内的结核分枝杆菌。
J Immunol. 2001 Sep 1;167(5):2734-42. doi: 10.4049/jimmunol.167.5.2734.
7
Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.细胞毒性T淋巴细胞克隆的裂解机制。克隆的抗原特异性CD4 +和CD8 + T淋巴细胞中的裂解活性和基因表达。
J Immunol. 1991 May 1;146(9):3242-9.
8
Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.穿孔素非依赖性CD8(+) T细胞介导的肺泡上皮细胞细胞毒性主要由肿瘤坏死因子-α介导:对Fas配体相对不敏感。
Am J Respir Cell Mol Biol. 1999 May;20(5):849-58. doi: 10.1165/ajrcmb.20.5.3585.
9
Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis.人类自身反应性CD4 + T细胞克隆利用穿孔素或Fas/Fas配体介导的途径进行靶细胞裂解。
J Immunol. 1997 Mar 15;158(6):2756-61.
10
IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.白细胞介素-4在体内可降低穿孔素介导的细胞毒性,并增强Fas配体介导的细胞毒性。
J Immunol. 2000 Apr 1;164(7):3487-93. doi: 10.4049/jimmunol.164.7.3487.

引用本文的文献

1
The potential of chimeric antigen receptor -T cell therapy for endocrine cancer.嵌合抗原受体T细胞疗法用于内分泌癌的潜力。
World J Surg Oncol. 2025 Apr 22;23(1):153. doi: 10.1186/s12957-025-03745-x.
2
Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells.源自培养皿的过继性细胞疗法:增强诱导多能干细胞
Transfus Med Hemother. 2024 Aug 26;52(1):27-41. doi: 10.1159/000540473. eCollection 2025 Feb.
3
Peripheral Blood CD8 T-Lymphocyte Immune Response in Benign and Subpopulations of Breast Cancer Patients.
外周血 CD8+T 淋巴细胞免疫应答在乳腺癌患者良性亚群中的研究。
Int J Mol Sci. 2024 Jun 11;25(12):6423. doi: 10.3390/ijms25126423.
4
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4 CAR T-cell antitumor activity.肿瘤内在对 IFN-γ 促凋亡作用的敏感性是 CD4 CAR T 细胞抗肿瘤活性的主要决定因素。
Nat Cancer. 2023 Jul;4(7):968-983. doi: 10.1038/s43018-023-00570-7. Epub 2023 May 29.
5
Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.解码策略以规避免疫调节剂半乳糖凝集素-1、-3 和-9 及其配体,作为癌症免疫治疗的新疗法。
Int J Mol Sci. 2022 Dec 8;23(24):15554. doi: 10.3390/ijms232415554.
6
A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells.一种特异性靶向 CADM1 膜结合片段的全人源抗体增强了人小细胞肺癌细胞的 T 细胞介导的杀伤作用。
Int J Mol Sci. 2022 Jun 21;23(13):6895. doi: 10.3390/ijms23136895.
7
Update for Advance CAR-T Therapy in Solid Tumors, Clinical Application in Peritoneal Carcinomatosis From Colorectal Cancer and Future Prospects.实体瘤中嵌合抗原受体 T 细胞治疗的最新进展:结直肠癌腹膜转移癌的临床应用及未来展望。
Front Immunol. 2022 Mar 25;13:841425. doi: 10.3389/fimmu.2022.841425. eCollection 2022.
8
[Mechanism of relapse and its therapeutic strategies after allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植后的复发机制及其治疗策略]
Zhonghua Xue Ye Xue Za Zhi. 2021 Oct 14;42(10):869-877. doi: 10.3760/cma.j.issn.0253-2727.2021.10.014.
9
Differentiation and Regulation of T Cells: A Balancing Act for Cancer Immunotherapy.T 细胞的分化和调控:癌症免疫治疗的平衡之举。
Front Immunol. 2021 May 3;12:669474. doi: 10.3389/fimmu.2021.669474. eCollection 2021.
10
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.间充质基质细胞递送溶瘤免疫疗法可提高 CAR-T 细胞的抗肿瘤活性。
Mol Ther. 2021 May 5;29(5):1808-1820. doi: 10.1016/j.ymthe.2021.02.004. Epub 2021 Feb 9.